Alzheimer's disease genetic mutation evokes ultrastructural alterations: Correlation to an intracellular Aβ deposition and the level of GSK-3β-P(Y216) phosphorylated form

NeuroToxicology

Volumn 30, Issue 4, 2009, Pages 581-588

  Pajak, Beata ^a   Songin, Martyna ^a   Strosznajder, Joanna B ^a   Gajkowska, Barbara ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Amyloid ; GSK 3 ; PC12 cells; Swedish double mutation; Ultrastructure

Indexed keywords

AMYLOID BETA PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; TAU PROTEIN; TYROSINE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; AUTOPHAGY; CELL STRAIN; CELL STRUCTURE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; ENDOSOME; ENZYME ACTIVITY; EXOCYTOSIS; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LYSOSOME; MICROGLIA; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; SENILE PLAQUE; WILD TYPE;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; AUTOPHAGY; ELECTROKYMOGRAPHY; ENDOSOMES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LYSOSOMES; MICROSCOPY, IMMUNOELECTRON; MUTATION; PC12 CELLS; PHOSPHORYLATION; RATS; SUBCELLULAR FRACTIONS; TRANSFECTION; TYROSINE;

EID: 67650960822     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2009.05.008     Document Type: Article

References (39)

1. 216 phosphorylation of glycogen synthase kinase-3β in cellular and animal models of neuronal degeneration. Proc Natl Acad Sci USA 97 (2000) 1074-11079
2. Borchelt D.R., Thinakaran G., Eckman C.B., Lee M.K., Davenport F., Ratovitsky T., et al. Familiar Alzheimer's disease-linked presenilin 1 variants elevate Abeta-42/1-40 ration in vitro and in vivo. Neuron 17 (1996) 1005-1013
3. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72 (1976) 248-254
4. Cataldo A.M., Hamilton D.J., Barnett J.L., Paskevich P.A., and Nixon R.A. Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J Neurosci 16 (1996) 186-199
5. Cataldo A.M., Barnett J.L., Pieroni C., and Nixon R.A. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J Neurosci 17 (1997) 6142-6151
6. Cataldo A.M., Peterhoff C., Troncoso J.T., Hyman B., and Nixon R. Endocytic pathway abnormalities precede beta-amyloid deposition in sporadic Alzheimer's disease: differential effects of APOE genotype and presenilin mutations. Am J Pathol 157 (2000) 277-286
7. Cataldo A.M., Rebeck G.W., Ghetti B., Hulette C., Lippa C., van Broeckhoven C., et al. Endocytic disturbances distinguish among subtypes of Alzheimer's disease and related disorders. Ann Neurol 50 (2001) 661-665
8. 2 level and arachidonic acid release via nitric oxide in APP-transfected PC12 cells. Acta Biochim Pol 54 (2007) 611-623
9. Chishti M.A., Yang D.S., Janus C., Phinney A.L., Patrick Horne P., Pearson J., et al. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 276 (2001) 21562-21570
10. David F., Clerqet F., and Lucote G. Familial Alzheimer's disease (FAD): co-segregation between alleles at the D21S11 DNA marker and the FAD gene in a particular pedigree. J Neurol 235 (1988) 485-486
11. Duff K., Eckman C., Zehr C., Yu X., Prada C.M., Perez-Tur J., et al. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383 (1996) 710-713
12. Grimes C.A., and Jope R.S. The multifaceted roles of glycogen synthase kinase 3 in cellular signaling. Prog Neurobiol 65 (2001) 391-426
13. Haass C., Schlossmacher M.G., Hung A.Y., Vigo-Pelfery C., Mellon A., Ostaszewski B.L., et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359 (1992) 322-325
14. Haass C., Lemere C.A., Capell A., Citron M., Seuber P., Schenk D., et al. The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway. Nat Med 1 (1995) 1291-1296
15. Hartigan J.A., and Johnson G.V. Transient increase in intracellular calcium results in prolonged site-selective increases in tau phosphorylation through a glycogen synthase kinase 3β-dependent pathway. J Biol Chem 274 (1999) 21395-21401
16. Holzer M., Holzapfel H.P., Zadlick D., Bruckner M.K., and Arendt T. Abnormally phosphorylated tau protein in Alzheimer's disease: heterogeneity of individual regional distribution and relationship to clinical severity. Neuroscience 63 (1994) 499-516
17. Hooper C., Killick R., and Lovestone S. The GSK3 hypothesis of Alzheimer's disease. J Neurochem 104 (2008) 1433-1439
18. Kaytor M.D., and Orr H.T. The GSK-3 beta signaling cascade and neurodegenerative disease. Curr Opin Neurobiol 12 (2002) 275-278
19. Kazimierczak A., Strosznajder J.B., and Adamczyk A. α-Synuclein enhances secretion and toxicity of amyloid beta peptides in PC12 cells. Neurochem Int 53 (2008) 263-269
20. Kim H.S., Kim E.M., Lee J.P., Park C.H., Kim S., Seo J.H., et al. C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3β expression. FASEB J 17 (2003) 1951-1953
21. Koo E.H., and Squazzo S.L. Evidence that production and release of amyloid beta-protein involves endocytic pathway. J Biol Chem 269 (1994) 322-325
22. Kourie J.I. Mechanisms of amyloid beta protein-induced modification in ion transport system: implications for neurodegenerative diseases. Cell Mol Neurobiol 21 (2001) 173-213
23. Lajoie P., Guay G., Dennis J.W., and Nabi I.R. The lipid composition of autophagic vacuoles regulates expression of multilamellar bodies. J Cell Sci 118 (2005) 1991-2003
24. Lambert J.C., Goumidi L., Vrieze F.W., Frigard B., Harris J.M., Cummings A., et al. The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum Mol Genet 9 (2000) 2275-2280
25. Leroy K., Yilmaz Z., and Brion J.P. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurons at different stages of neurofibrillary degeneration. Neuropathol Appl Neurobiol 33 (2007) 43-55
26. Pappolla M.A., Omar R.A., Sambamurti K., Anderson J.P., and Robakis N.K. The genesis of the senile plaque. Further evidence in support of its neuronal origin. Am J Pathol 141 (1992) 1151-1159
27. Pei J.J., Braak E., Braak H., Grundke-Iqbal K., Winblad B., and Cowburn R.F. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer's disease neurofibrillary changes. J Neuropathol Exp Neurol 58 (1999) 1010-1019
28. Pei J.J., Braak E., Braak H., Grunde-Iqbal I., Iqbal K., Winblad B., et al. Distribution of active glycogen synthase kinase 3 beta(GSK-3 beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol 58 (1999) 1010-1019
29. Rankin C.A., Sun Q., and Gamblin T.C. Tau phosphorylation by GSK-3b promotes tangle-like filament morphology. Mol Neurodegener 2 (2007) 12
30. Rankin C.A., Sun Q., and Gamblin T.C. Pre-assembled tau filaments phosphorylated by GSK-3b from large tangle-like structures. Neurobiol Dis 31 (2008) 368-377
31. Rankin C.A., Sun Q., and Gamblin T.C. Pre-assembled tau filaments phosphorylated by GSK-3β form large tangle-like structures. Neurobiol Dis 31 (2008) 368-377
32. Ryder J., Su Y., Liu F., Li B., Zhou Y., and Ni B. Divergent roles of GSK3 and CDK5 in APP processing. Biochem Biophys Res 312 (2003) 922-929
33. Sahoo S., Tizon B., Figliola M., and Levy E. Multiple mechanisms of neuroprotection by cystatin C: inhibition of Aβ deposition, induction of autophagy, and induction of proliferation. Alzheimer's Dementia 4 (2008) T114
34. Sato S., Tatebayashi Y., Akagi T., Chui D.H., Murayama M., Miyasaka T., et al. Abberant tau phosphorylation by glycogen synthase kinase 3-beta and JNK3 induces oligomeric tau fibrils in COS-7cells. J Biol Chem 277 (2002) 42060-42065
35. Song Y.S., Park H.J., Kim S.Y., Lee S.H., Yoo H.S., Lee H.S., et al. Protective role of Bcl-2 on beta-amyloid-induced cell death of differentiated PC12 cells: reduction of NF-kappaB and p38 MAP kinase activation. Nerosci Res 49 (2004) 69-80
36. Terwel D., Muyllaert D., Dewachter I., Borghgraef P., Croes S., Devijver H., et al. Amyloid activates GSK-3β to aggravate neuronal tauopathy in bigenic mice. Neurobiol 172 (2008) 786-798
37. Tesco G., and Tanzi R.E. GSK3 beta forms a tetrameric complex with enogenous PS1-CTF/NTF and beta-catenin. Effects of the D257/D385A and FAD-linked mutations. Ann N Y Acad Sci 920 (2000) 227-232
38. Xu Y., Kim H.S., Joo Y., Choi Y., Chang K.A., Park C.H., et al. Intracellular domains of amyloid precursor-like protein 2 interact with CP2 transcription factor in the nucleus and induce glycogen synthase kinase-3β expression. Cell Death Differ 14 (2007) 79-91
39. Yu W.H., Cuervo A.M., Kumar A., Peterhoff C.M., Schmidt S.D., Lee J.H., et al. Macroautophagy-a novel beta-amyloid peptide-generating pathway activated in Alzheimer disease. J Cell Biol 171 (2005) 87-98